Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-18

FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)

View source ↗

Summary

FDA approved the Original Application for Betamethasone Dipropionate USP, 0.05% (topical corticosteroid) submitted by TruPharma LLC. It is a generic topical the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betamethasone Dipropionate USP, 0.05% (betamethasone dipropionate)

Snippet

ORIG AP for BETAMETHASONE DIPROPIONATE USP, 0.05% (BETAMETHASONE DIPROPIONATE USP, 0.05%)